The Total Peptide Management™ program is a customized service platform. Offering a broad portfolio of peptides, value-added services, and expert consultation, the program helps companies bring new and innovative drugs to market faster.
- Process development
- Scale-up production
- Analytical and process validation
- Stability studies
- Chemistry, Manufacturing, and Controls (CMC)
- Drug Master Files (DMF)
- Regulatory support
The program leverages the experience and expertise of American Peptide Company's leadership team to help customers properly select peptides and follow the correct procedures and compliance guidelines to streamline the drug development and manufacturing process.
Exceeding conventional requirements, the Total Peptide Management program mandates the use of
current Good Manufacturing Practices (cGMP) in non-GMP applications during the early phases of drug development. This ensures efficient scale-up from the clinical phase to full manufacturing when a successful peptide-based therapy is developed.